Cargando…

Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders

Detalles Bibliográficos
Autores principales: Fillmore, Nathanael R., La, Jennifer, Wu, Julie Tsu-Yu, Corrigan, June K., Branch-Elliman, Westyn, Monach, Paul, Brophy, Mary T., Do, Nhan V., Munshi, Nikhil C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659994/
https://www.ncbi.nlm.nih.gov/pubmed/37647600
http://dx.doi.org/10.1182/bloodadvances.2023011063
_version_ 1785137666512125952
author Fillmore, Nathanael R.
La, Jennifer
Wu, Julie Tsu-Yu
Corrigan, June K.
Branch-Elliman, Westyn
Monach, Paul
Brophy, Mary T.
Do, Nhan V.
Munshi, Nikhil C.
author_facet Fillmore, Nathanael R.
La, Jennifer
Wu, Julie Tsu-Yu
Corrigan, June K.
Branch-Elliman, Westyn
Monach, Paul
Brophy, Mary T.
Do, Nhan V.
Munshi, Nikhil C.
author_sort Fillmore, Nathanael R.
collection PubMed
description
format Online
Article
Text
id pubmed-10659994
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-106599942023-09-01 Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders Fillmore, Nathanael R. La, Jennifer Wu, Julie Tsu-Yu Corrigan, June K. Branch-Elliman, Westyn Monach, Paul Brophy, Mary T. Do, Nhan V. Munshi, Nikhil C. Blood Adv Research Letter The American Society of Hematology 2023-09-01 /pmc/articles/PMC10659994/ /pubmed/37647600 http://dx.doi.org/10.1182/bloodadvances.2023011063 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Fillmore, Nathanael R.
La, Jennifer
Wu, Julie Tsu-Yu
Corrigan, June K.
Branch-Elliman, Westyn
Monach, Paul
Brophy, Mary T.
Do, Nhan V.
Munshi, Nikhil C.
Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
title Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
title_full Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
title_fullStr Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
title_full_unstemmed Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
title_short Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
title_sort even after sars-cov-2 booster, there is increased covid-19 breakthrough infection in patients with plasma cell disorders
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659994/
https://www.ncbi.nlm.nih.gov/pubmed/37647600
http://dx.doi.org/10.1182/bloodadvances.2023011063
work_keys_str_mv AT fillmorenathanaelr evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders
AT lajennifer evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders
AT wujulietsuyu evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders
AT corriganjunek evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders
AT branchellimanwestyn evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders
AT monachpaul evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders
AT brophymaryt evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders
AT donhanv evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders
AT munshinikhilc evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders